Emma Koehn

Australian clinicians say the federal government's war on high specialist fees overlooks the soaring yet often invisible costs of providing care, warning a focus on fee caps alone won't fix the nation's fractured health systems.

The investigational weight-loss drug retatrutide cut sleep apnoea events by 25 to 34 an hour at its two highest doses, versus about 10 with placebo, in two industry-funded phase 3 trials.

Dr Isabella Tan The withdrawal of a pioneering cuffless blood pressure monitor from Australia highlights the hurdles facing wearable BP technology before it can become routine clinical practice, researchers say.

The federal government's expert committee on Medicare funding is reviewing the MBS items for catheter-based cardiac ablation after industry argued

Children and adolescents with type 2 diabetes should start on an GLP-1RA or SGLT2i medication if they do not achieve glycaemic targets after three months of treatment with metformin, new Australian guidelines state.

Professor Anne Holland Globally-renowned COPD experts have proposed a new consensus definition of “severe COPD” in hopes of improving

Dr Haley Naik New US guidelines for the treatment of hidradenitis suppurativa have endorsed the use of biologics adalimumab, bimekizumab, infliximab, and

Clinicians who encourage patients to inappropriately access their superannuation to pay for treatments or provide misleading information to secure

NSW Health Minister Ryan Park The NSW Government will spend $17 million to clear a backlog of about 20,000 overdue endoscopy procedures

The Federal Government's Medical Services Advisory Committee has again deferred advice on funding CGMs for type 2 diabetes requiring insulin, citing limited evidence and uncertain cost effectiveness.